- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
连续性肾脏替代治疗I型心肾综合征患者的临床分析.DOC
连续性肾脏替代治疗I型心肾综合征患者的临床分析
215006 苏州,苏州大学医学部(李军辉);200233 上海,上海交通大学附属第六人民医院肾内科(李军辉 盛晓华 程东生 费杨 刘玉梅 范瑛 汪年松)
基金项目、上海市卫生和计划生育委员会课题(201440531)、上海市科委重大课题(11DZ1973103)科研基金资助
通讯作者:盛晓华 xiaohuasheng@ 汪年松 wangniansong2012@163.com
【摘要:目的 分析行连续性肾脏替代治疗I型心肾综合征患者的临床特征及预后。方法上海交通大学附属第六人民医院2009年月2014年月住院行I型回顾性分析I型结果I型AKI 2期7例(20%)AKI 3期28例(80%), 平均器官衰竭数为3.6个,APACHE II评分为24.9分(48.6%),死亡18例(51.4%),两组比较,在年龄、心功能分级、平均器官衰竭数目、APACHE II评分平均动脉压平均血小板体积、血尿素氮血糖升压药应用(P<0.05)。 结论行I型APACHE II评分
【关键词 连续性肾脏替代治疗心肾综合征住院
Clinical analysis of continuous renal replacement therapy for patients with cardiorenal syndrome type 1 LI Junhui, SHENG Xiaohua, CHENG Dongsheng, FEI Yang, LIU Yumei, WANG Niansong. School of Medicine, Soochow University, Suzhou, Jiangsu 215006, China; Department of Nephrology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai 200233, China
Corresponding author : SHENG Xiaohua(E-mail: xiaohuasheng@) and WANG Niansong(E-mail: wangniansong2012@163.com ).
【Abstract】 Objective The aim of this study was to analyze the risk factor and prognosis of continuous renal replacement therapy(CRRT)for patients with cardiorenal syndrome type 1(type 1 CRS ).Methods We recruited 35 type 1 CRS patients in our hospital from February 2009 to September 2014. All the patients received CRRT. Clinical data of adult patients were retrospectively analyzed. Results In the 35 patients who received CRRT, the percentage of stage II, stage III AKI were 20% and 80%, respectively. The average number of organ failure was 3.6. The score of APACHE II was 24.9. Of the 35 patients in the period of investigation, 17 patients (48.6%) were survived and 18 patients (51.4%) were dead. There were significant difference in age, cardiac function grading, average number of organ failure,?the score of APACHE II, mean arterial pressure(MAP), mean platelet volume(MPV), blood urea nitrogen(BUN) and Fasting blood glucose(FBG) between the survive group and death group(P<0.05). Conclusion The prognos
文档评论(0)